University of British Columbia
Translational histopathology and preclinical intrathecal drug delivery in traumatic spinal cord injury
Abstract
dc:descriptionTraumatic spinal cord injury (SCI) initiates complex histopathological changes that hinder neural repair and functional recovery. Understanding the structural and cellular organization of the injured spinal cord is therefore crucial for developing effective therapies. This thesis investigates injury-induced changes, extracellular matrix (ECM) remodeling, and motor network integrity across porcine and human SCI, and evaluates a novel therapeutic strategy targeting inhibitory ECM-components. First, the histopathological architecture of thoracic contusion/compression SCI was characterized in a porcine model to assess its translational relevance. At 14 weeks post-injury, the injury epicenter comprised a dense, collagen-rich fibrotic core. Surrounding this core, reactive astrocytes (identified by glial fibrillary acidic protein; GFAP) and chondroitin sulfate proteoglycans (CSPGs) extended rostrocaudally (at least 30 mm), forming a diffuse astroglial-CSPG expression pattern rather than a well-defined scar. Perineuronal nets (PNNs) surrounding alpha motor neurons (αMNs) exhibited no detectable differences in Wisteria floribunda agglutinin (WFA) expression between uninjured and injured spinal cords across spinal levels, suggesting no detectable change in PNN-architecture. Similarly, serotonergic innervation appeared reduced below the injury but did not differ significantly between groups. Together, these findings suggest limited detectable remodeling within motor circuits below the injury despite substantial ECM-remodeling at the injury site. Building on this platform, the biodistribution and efficacy of a CSPG-binding peptide (CBP) were investigated to mitigate CSPG-mediated inhibition. FITC-conjugated CBP was delivered intrathecally for 12 weeks starting 2 weeks post-injury. The peptide localized within the meninges without penetrating the spinal parenchyma or reducing CSPG-expression, and no functional improvements were observed. Instead, chronic infusion triggered inflammatory responses marked by T-cell infiltration in subarachnoid and perivascular spaces, underscoring the importance of optimized delivery strategies. Finally, histopathological analyses of post-mortem human SCI tissue from the International Spinal Cord Injury Biobank (ISCIB) revealed collagen-rich fibrosis, CSPG- and GFAP-upregulation, consistent with porcine findings. Schwannosis was confirmed in chronic cases, highlighting the long-lasting nature of human SCI pathology. Collectively, these studies characterize conserved mechanisms of fibrotic and astroglial remodeling following SCI. By integrating large-animal and human data, this work defines a histopathological continuum of SCI pathology and provides an essential translational framework for the development of future reparative therapies.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy - PhD
- Level thesis:degree_level
- doctoral
- Discipline thesis:degree_discipline
- Neuroscience
- Grantor dc:publisher
- University of British Columbia
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Jarlsdóttir, Sigrún
- Contributors dc:contributor
-
- Kwon, Brian K.
Rights
dc:rights- Statement dc:rights
-
- Attribution-NonCommercial-NoDerivatives 4.0 International
- Language dc:language
- eng
Identifiers
dc:identifier.*- Handle dc:identifier
- http://hdl.handle.net/2429/95179